You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma

  • Technology appraisal guidance
  • Reference number: TA658
  • Published:  18 November 2020
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Education
  2. Guidance into practice

Tools and resources

Tools and resources to help you put the guidance into practice.

Education

  • Managed access agreement (PDF 426 KB)

    Published:
    18 November 2020

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top